These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35893680)

  • 21. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult hepatitis B virus coinfection in HIV-positive African migrants to the UK: a point prevalence study.
    Chadwick D; Doyle T; Ellis S; Price D; Abbas I; Valappil M; Geretti AM
    HIV Med; 2014 Mar; 15(3):189-92. PubMed ID: 24118868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study.
    Ionita G; Malviya A; Rajbhandari R; Schluter WW; Sharma G; Kakchapati S; Rijal S; Dixit S
    Int J Infect Dis; 2017 Jul; 60():64-69. PubMed ID: 28483724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV-hepatitis B coinfection.
    Dezanet LNC; Maylin S; Gabassi A; Rougier H; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Delaugerre C; Zoulim F; Lacombe K; Boyd A
    AIDS; 2020 Nov; 34(13):1943-1949. PubMed ID: 32773480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B.
    Dezanet LNC; Miailhes P; Lascoux-Combe C; Chas J; Maylin S; Gabassi A; Rougier H; Delaugerre C; Lacombe K; Boyd A
    Liver Int; 2021 Dec; 41(12):2874-2884. PubMed ID: 34297463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiretroviral Effects on HBV/HIV Co-infection and the Natural History of Liver Disease.
    Wyles DL
    Clin Liver Dis; 2019 Aug; 23(3):473-486. PubMed ID: 31266621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection.
    Malagnino V; Bottero J; Miailhes P; Lascoux-Combe C; Girard PM; Zoulim F; Lacombe K; Boyd A
    J Med Virol; 2019 Apr; 91(4):630-641. PubMed ID: 30431661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
    Hamers RL; Zaaijer HL; Wallis CL; Siwale M; Ive P; Botes ME; Sigaloff KC; Hoepelman AI; Stevens WS; Rinke de Wit TF;
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):174-82. PubMed ID: 23892239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection.
    Singh KP; Zerbato JM; Zhao W; Braat S; Deleage C; Tennakoon GS; Mason H; Dantanarayana A; Rhodes A; Rhodes JW; Torresi J; Harman AN; Revill PA; Crane M; Estes JD; Avihingsanon A; Lewin SR; Audsley J
    PLoS Pathog; 2020 Sep; 16(9):e1008744. PubMed ID: 32898182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).
    Liégeois F; Boyer S; Eymard-Duvernay S; Carrieri P; Kouanfack C; Domyeum J; Maradan G; Ducos J; Mpoudi-Ngolé E; Spire B; Delaporte E; Kuaban C; Vidal L; Laurent C;
    BMC Infect Dis; 2020 Jan; 20(1):49. PubMed ID: 31941464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B and human immunodeficiency virus co-infection.
    Phung BC; Sogni P; Launay O
    World J Gastroenterol; 2014 Dec; 20(46):17360-7. PubMed ID: 25516647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.
    Leprêtre A; Ba I; Lacombe K; Maynart M; Toufik A; Ndiaye O; Kane CT; Gozlan J; Tine J; Ndoye I; Raguin G; Girard PM
    J Int AIDS Soc; 2015; 18(1):19888. PubMed ID: 26004637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus genotype G: prevalence and impact in patients co-infected with human immunodeficiency virus.
    Dao DY; Balko J; Attar N; Neak E; Yuan HJ; Lee WM; Jain MK
    J Med Virol; 2011 Sep; 83(9):1551-8. PubMed ID: 21739445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
    Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
    Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus.
    Huang YS; Sun HY; Chang SY; Chuang YC; Su YC; Liu WC; Hung CC
    Int J Antimicrob Agents; 2022; 60(5-6):106682. PubMed ID: 36279976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults.
    Hawkins C; Christian B; Fabian E; Macha I; Gawile C; Mpangala S; Ulenga N; Thio CL; Ammerman LR; Mugusi F; Fawzi W; Green R; Murphy R
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):298-302. PubMed ID: 29016448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and Risk Factors of HBV and HCV Co-Infection Among People Living with HIV in an Egyptian Setting.
    El-Ghitany EM; Farghaly AG; Alkassabany YM
    Curr HIV Res; 2021; 19(6):514-524. PubMed ID: 34353267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.
    Grant J; Agbaji O; Kramvis A; Yousif M; Auwal M; Penugonda S; Ugoagwu P; Murphy R; Hawkins C
    Trop Med Int Health; 2017 Jun; 22(6):744-754. PubMed ID: 28376292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.
    Lee TH; Hunt CM; Maier MM; Lowy E; Beste LA
    Clin Infect Dis; 2022 Oct; 75(9):1529-1536. PubMed ID: 35349635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.